Biotech Values

[RockRat]

So how come the market doesn't appear to be applying the lag from inspection to approval, which seems to be several months, at least. If that's a good premise, the Bernstein analyst is going to look stupid calling for Teva's version to be approved before year end.

Regards, RockRat